ZJYL - JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

ZJYL - JIN MEDICAL INTERNATIONAL LTD. Ordinary Shares

https://www.zhjmedical.com

Recent News

Powered by Alpha Vantage

Jin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing Facility

GlobeNewswire • 1 month, 4 weeks ago • score: 0.25

Beijing, China, July 15, 2025 ( GLOBE NEWSWIRE ) -- Jin Medical International Ltd. ( Nasdaq: ZJYL ) ( "Jin Medical", and together with all its subsidiaries, the "Company" ) , a Nasdaq-listed provider of rehabilitation medical equipment, announced today that its wholly owned subsidiary, ZhongJin ...

Jin Medical International, Nio And Other Big Stocks Moving Lower In Monday's Pre-Market Session - NIO ( NYSE:NIO )

Benzinga • 11 months, 3 weeks ago • score: 0.13

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 50 points on Monday. Shares of Jin Medical International Ltd. ZJYL fell sharply in today's pre-market trading after jumping around 55% on Friday. Jin Medical International shares dipped 23.5% to $3.12 in ...

How Is The Market Feeling About Jin Medical International? - Jin Medical International ( NASDAQ:ZJYL )

Benzinga • 1 year, 6 months ago • score: 0.25

Jin Medical International's ZJYL short percent of float has fallen 95.59% since its last report. The company recently reported that it has 39 thousand shares sold short, which is 0.1% of all regular shares that are available for trading.

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Jin Medical International Ltd. designs and manufactures wheelchairs and living aids products.

52W High

$4.08

52W Low

$0.50

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

9.84

Valuation

Rich

As of 2024-12-31 (Overview)

Trailing P/E (<15 better)

61.98

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

35.10

EV/Revenue (<3 favorable)

3.59

P/S (TTM) (<3 favorable)

4.25

P/B (<3 favorable)

3.48

Ownership

Retail‑heavy

Source: Overview

Insiders (1–5% typical)

75.84%

Institutions (25–75% balanced)

0.45%

Shares Outstanding

156,547,000

Float

37,824,900

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2024-12-31 (Overview)

Revenue (TTM)

22,826,600

Gross Profit (TTM)

8,345,600

EPS (TTM)

0.01

Profit Margin (>10% good)

0.08%

Operating Margin (TTM) (higher better)

-0.05%

ROE (TTM) (>15% strong)

0.06%

EPS YoY (Quarterly) (>10% good)

0.68

Revenue YoY (Quarterly) (>8% good)

-0.06

Momentum

Value

N/A

Previous

N/A

Trend

—

Signal Cross

No cross

As of

—